RT Journal Article T1 Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing. A1 Gonzalez-Juanatey, Carlos A1 Anguita-Sanchez, Manuel A1 Barrios, Vivencio A1 Nuñez-Gil, Ivan A1 Gomez-Doblas, Juan Jose A1 Garcia-Moll, Xavier A1 Lafuente-Gormaz, Carlos A1 Rollan-Gomez, Maria Jesus A1 Peral-Disdier, Vicente A1 Martinez-Dolz, Luis A1 Rodriguez-Santamarta, Miguel A1 Viñolas-Prat, Xavier A1 Soriano-Colome, Toni A1 Muñoz-Aguilera, Roberto A1 Plaza, Ignacio A1 Curcio-Ruigomez, Alejandro A1 Orts-Soler, Ernesto A1 Segovia, Javier A1 Fanjul, Víctor A1 Cequier, Angel K1 MACE K1 Coronary artery disease K1 Diabetes mellitus K1 Electronic health records K1 Natural language processing K1 Risk factors AB Patients with Type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are at high risk of developing major adverse cardiovascular events (MACE). This is a multicenter, retrospective, and observational study performed in Spain aimed to characterize these patients in a real-world setting. Unstructured data from the Electronic Health Records were extracted by EHRead®, a technology based on Natural Language Processing and machine learning. The association between new MACE and the variables of interest were investigated by univariable and multivariable analyses. From a source population of 2,184,662 patients, we identified 4072 adults diagnosed with T2DM and CAD (62.2% male, mean age 70 ± 11). The main comorbidities observed included arterial hypertension, hyperlipidemia, and obesity, with metformin and statins being the treatments most frequently prescribed. MACE development was associated with multivessel (Hazard Ratio (HR) = 2.49) and single coronary vessel disease (HR = 1.71), transient ischemic attack (HR = 2.01), heart failure (HR = 1.32), insulin treatment (HR = 1.40), and percutaneous coronary intervention (PCI) (HR = 2.27), whilst statins (HR = 0.73) were associated with a lower risk of MACE occurrence. In conclusion, we found six risk factors associated with the development of MACE which were related with cardiovascular diseases and T2DM severity, and treatment with statins was identified as a protective factor for new MACE in this study. PB MDPI SN 2077-0383 YR 2022 FD 2022-10-22 LK http://hdl.handle.net/10668/21357 UL http://hdl.handle.net/10668/21357 LA en NO González-Juanatey C, Anguita-Sánchez M, Barrios V, Núñez-Gil I, Gómez-Doblas JJ, García-Moll X, et al. Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing. J Clin Med. 2022 Oct 11;11(20):6004 DS RISalud RD Jul 6, 2025